🇺🇸 FDA
Patent

US 11571484

Compositions that target tumor-associated macrophages and methods of use therefor

granted A61KA61K38/00A61K38/212

Quick answer

US patent 11571484 (Compositions that target tumor-associated macrophages and methods of use therefor) held by SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
Grant date
Tue Feb 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/00, A61K38/212, A61K45/06, A61K49/0041